Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the websites listed below. If a full
report of the study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on the website, type “NCT03836677”
into the search box, and click “Search”.
• www.clinicaltrialsregister.eu Once you are on the website, click “Home
and Search”, then type “2018-001704-10” in the search box and click
“Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“D5980C00019” into the search box, and click “Find a Study”.
Full Trial Title: A Randomized, Double-blind, Two Treatment, Two Period,
Chronic Dosing (4 weeks), Cross-Over, Multi-Center Pilot Study to Evaluate the
Effects of Budesonide/Glycopyrronium/Formoterol Fumarate and Glycopyrronium/
Formoterol Fumarate on Specific Image-Based Airway Volumes and Resistance in
Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease.
AstraZeneca Protocol Number: D5980C00019
National Clinical Trials Number: NCT03836677
EudraCT Number: 2018-001704-10
AstraZeneca sponsored this study and has its headquarters in Cambridge, UK.
The phone number for the AstraZeneca Information Center is +1 877 240 9479.
Thank you!
Clinical study participants belong to a large community of people who take part in
clinical research around the world. They help researchers answer important health
questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research
Participation (CISCRP) is a non-profit organization focused
on educating and informing the public about clinical research
participation. CISCRP is not involved in recruiting participants for
clinical studies, nor is it involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 1100 • Boston, MA 02109
1-877-MED-HERO • www.ciscrp.org
Version 1.0 2020_10_08 12